Matches in SemOpenAlex for { <https://semopenalex.org/work/W4207048871> ?p ?o ?g. }
- W4207048871 endingPage "259" @default.
- W4207048871 startingPage "259" @default.
- W4207048871 abstract "The new palladium agent Pd2Spermine (Spm) has been reported to exhibit promising cytotoxic properties, while potentially circumventing the known disadvantages associated to cisplatin therapeutics, namely acquired resistance and high toxicity. This work presents a nuclear magnetic resonance (NMR) metabolomics study of brain extracts obtained from healthy mice, to assess the metabolic impacts of the new Pd2Spm complex in comparison to that of cisplatin. The proton NMR spectra of both polar and nonpolar brain extracts were analyzed by multivariate and univariate statistics, unveiling several metabolite variations during the time course of exposition to each drug (1-48 h). The distinct time-course dependence of such changes revealed useful information on the drug-induced dynamics of metabolic disturbances and recovery periods, namely regarding amino acids, nucleotides, fatty acids, and membrane precursors and phospholipids. Putative biochemical explanations were proposed, based on existing pharmacokinetics data and previously reported metabolic responses elicited by the same metal complexes in the liver of the same animals. Generally, results suggest a more effective response of brain metabolism towards the possible detrimental effects of Pd2Spm, with more rapid recovery back to metabolites' control levels and, thus, indicating that the palladium drug may exert a more beneficial role than cDDP in relation to brain toxicity." @default.
- W4207048871 created "2022-01-26" @default.
- W4207048871 creator A5033443157 @default.
- W4207048871 creator A5039656941 @default.
- W4207048871 creator A5050251537 @default.
- W4207048871 creator A5067885139 @default.
- W4207048871 creator A5072670917 @default.
- W4207048871 creator A5081991561 @default.
- W4207048871 creator A5085024755 @default.
- W4207048871 creator A5088798919 @default.
- W4207048871 date "2022-01-22" @default.
- W4207048871 modified "2023-10-14" @default.
- W4207048871 title "Metabolic Impact of Anticancer Drugs Pd2Spermine and Cisplatin on the Brain of Healthy Mice" @default.
- W4207048871 cites W1144254266 @default.
- W4207048871 cites W1502721826 @default.
- W4207048871 cites W1503927740 @default.
- W4207048871 cites W1583604396 @default.
- W4207048871 cites W1680532198 @default.
- W4207048871 cites W1823480259 @default.
- W4207048871 cites W1832113570 @default.
- W4207048871 cites W1975464130 @default.
- W4207048871 cites W1980411311 @default.
- W4207048871 cites W1983552453 @default.
- W4207048871 cites W1993397541 @default.
- W4207048871 cites W2005085550 @default.
- W4207048871 cites W2007825898 @default.
- W4207048871 cites W2008672509 @default.
- W4207048871 cites W2009638375 @default.
- W4207048871 cites W2012108057 @default.
- W4207048871 cites W2013864401 @default.
- W4207048871 cites W2017619517 @default.
- W4207048871 cites W2049069390 @default.
- W4207048871 cites W2051366884 @default.
- W4207048871 cites W2056669802 @default.
- W4207048871 cites W2064445380 @default.
- W4207048871 cites W2068542211 @default.
- W4207048871 cites W2072861812 @default.
- W4207048871 cites W2074286443 @default.
- W4207048871 cites W2080815447 @default.
- W4207048871 cites W2089016502 @default.
- W4207048871 cites W2094682461 @default.
- W4207048871 cites W2102118295 @default.
- W4207048871 cites W2110065044 @default.
- W4207048871 cites W2117161243 @default.
- W4207048871 cites W2125715541 @default.
- W4207048871 cites W2145022634 @default.
- W4207048871 cites W2149069617 @default.
- W4207048871 cites W2169326740 @default.
- W4207048871 cites W2195557884 @default.
- W4207048871 cites W2235819251 @default.
- W4207048871 cites W2283198732 @default.
- W4207048871 cites W2285371113 @default.
- W4207048871 cites W2295182096 @default.
- W4207048871 cites W2321697502 @default.
- W4207048871 cites W2463218221 @default.
- W4207048871 cites W2550426261 @default.
- W4207048871 cites W2593019284 @default.
- W4207048871 cites W2606152360 @default.
- W4207048871 cites W2609511098 @default.
- W4207048871 cites W2612283583 @default.
- W4207048871 cites W2619863800 @default.
- W4207048871 cites W2743582201 @default.
- W4207048871 cites W2767683865 @default.
- W4207048871 cites W2772778871 @default.
- W4207048871 cites W2783408851 @default.
- W4207048871 cites W2791452006 @default.
- W4207048871 cites W2792174611 @default.
- W4207048871 cites W2892844483 @default.
- W4207048871 cites W2900850467 @default.
- W4207048871 cites W2901196413 @default.
- W4207048871 cites W2901548587 @default.
- W4207048871 cites W2910892797 @default.
- W4207048871 cites W2912062069 @default.
- W4207048871 cites W2912651186 @default.
- W4207048871 cites W2918868724 @default.
- W4207048871 cites W2938031258 @default.
- W4207048871 cites W2952805186 @default.
- W4207048871 cites W2963502640 @default.
- W4207048871 cites W2965191969 @default.
- W4207048871 cites W2982135574 @default.
- W4207048871 cites W2989497982 @default.
- W4207048871 cites W2997951819 @default.
- W4207048871 cites W3021777890 @default.
- W4207048871 cites W3029733610 @default.
- W4207048871 cites W3040005313 @default.
- W4207048871 cites W3103349938 @default.
- W4207048871 cites W3105897094 @default.
- W4207048871 cites W3130084178 @default.
- W4207048871 cites W3130947638 @default.
- W4207048871 cites W3165519449 @default.
- W4207048871 cites W3188877756 @default.
- W4207048871 cites W3203433662 @default.
- W4207048871 cites W4296816736 @default.
- W4207048871 doi "https://doi.org/10.3390/pharmaceutics14020259" @default.
- W4207048871 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35213994" @default.
- W4207048871 hasPublicationYear "2022" @default.
- W4207048871 type Work @default.
- W4207048871 citedByCount "4" @default.